Braathen et al., 2019 - Google Patents
In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 daysBraathen et al., 2019
View PDF- Document ID
- 7560029171533732292
- Author
- Braathen H
- Sivertsen J
- Lunde T
- Kristoffersen E
- Assmus J
- Hervig T
- Strandenes G
- Apelseth T
- Publication year
- Publication venue
- Transfusion
External Links
Snippet
BACKGROUND Cold storage of platelets may extend shelf life compared to room temperature storage. This study aimed to investigate in vitro platelet quality and function in cold‐stored and delayed‐cold‐stored nonagitated apheresis platelets in platelet additive …
- 238000003860 storage 0 title abstract description 125
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Braathen et al. | In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days | |
Johnson et al. | The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine‐expressing platelets and platelet microparticles | |
Meledeo et al. | Optimizing whole blood storage: hemostatic function of 35‐day stored product in CPD, CP2D, and CPDA‐1 anticoagulants | |
Johnson et al. | In vitro comparison of cryopreserved and liquid platelets: potential clinical implications | |
Apelseth et al. | In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma‐irradiated single‐donor platelet concentrates during long‐term storage | |
De Wildt‐Eggen et al. | Storage of platelets in additive solutions: effects of magnesium and/or potassium | |
Valeri et al. | Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at− 80° C without postthaw processing | |
Wood et al. | Maximising platelet availability by delaying cold storage | |
Sivertsen et al. | Cold‐stored leukoreduced CPDA‐1 whole blood: in vitro quality and hemostatic properties | |
McCully et al. | The International Normalized Ratio overestimates coagulopathy in stable trauma and surgical patients | |
Johnson et al. | Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets | |
Cid et al. | In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets | |
Diedrich et al. | In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution | |
Slichter et al. | Platelets stored in whole blood at 4° C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function | |
Huish et al. | Effect of storage of plasma in the presence of red blood cells and platelets: re‐evaluating the shelf life of whole blood | |
Chang et al. | Previous cryopreservation alters the natural history of the red blood cell storage lesion | |
Valeri et al. | Automation of the glycerolization of red blood cells with the high‐separation bowl in the Haemonetics ACP 215 instrument | |
Reece et al. | Near‐patient platelet function testing in patients undergoing coronary artery surgery: a pilot study | |
Bynum et al. | Evaluation of a lyophilized platelet‐derived hemostatic product | |
Johnson et al. | Extended storage of thawed platelets: refrigeration supports postthaw quality for 10 days | |
Tchir et al. | Rejuvenation of ATP during storage does not reverse effects of the hypothermic storage lesion | |
Lozano et al. | Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage | |
Tynngård et al. | In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma‐irradiated platelets | |
Johnson et al. | Freezing expired platelets does not compromise in vitro quality: an opportunity to maximize inventory potential | |
Berzuini et al. | One size doesn’t fit all: should we reconsider the introduction of cold-stored platelets in blood bank inventories? |